Each day, Maria Rios prays the same prayer.
"Lord you gave me this. You will see me through it. Just, please, hold my hand and walk with me," says Maria.
Last year, Dr. Daniel Jacobs confirmed the pain and fatigue Maria suffers from is caused by Multiple Sclerosis.
"There's days that I feel great. There's days I can't get out of bed."
Maria is in the early stages of ms, and she hasn't yet received the standard drug treatments to slow its debilitating effects. For this reason, her doctor says she's a prime candidate to participate in a study of this new drug, called Campath 1H.
An MRI shows visible white spots or plaques in the brain. They form when the protective myelin covering the nerves is destroyed by white blood cells. Campath 1H targets those destructive white blood cells.
"We have a chance to stop the disease in its tracks and prevent disability a five, ten, twenty, or twenty-five years down the road," says Dr. Daniel Jacobs.
For Maria, the new drug might be the miracle she's been praying for, but if it's not, she'll continue to rely on her faith.
"Even if I'm crippled, even if I can't move from a bed, I'm alive, and that's what counts," Maria says.
For more information, contact:
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.